Trademark Overview
On Friday, September 29, 2023, a trademark application was filed for GENOSCORE-ACT with the United States Patent and Trademark Office. The USPTO has given the GENOSCORE-ACT trademark a serial number of 98203382. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 16, 2024. This trademark is owned by Cytox Limited. The GENOSCORE-ACT trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Software algorithms programs to aid early diagnosis of degenerative diseases, particularly Alzheimer's; computer software to aid early diagnosis of degenerative diseases, particularly Alzheimer's; software algorithms programs to aid early diagnosis of progressive diseases, particularly Alzheimer's; computer software to aid early diagnosis of progressive diseases, particularly Alzheimer's
Medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical treatment services; cognitive therapy services; cognitive and psychological examination and testing services; information, advice and consultancy in relation to all the aforesaid services; all the aforesaid being in the fields of dementia and cognitive decline
Software as a service; advisory services relating to science; analysis of human tissues for medical research; biochemical research, development and analysis; biological research, development and analysis; biotechnological research, development and analysis; chemical research and analysis; clinical research; consultancy relating to laboratory testing; laboratory research; laboratory services; medical research; providing temporary use of non-downloadable computer software for accessing and using a cloud computing network; providing temporary use of web-based software; providing temporary use of non-downloadable computer software; research and development services in the field of gene expression systems; providing temporary use of non-downloadable computer software to aid early diagnosis of degenerative diseases; providing temporary use of non-downloadable computer software to aid early diagnosis of progressive diseases; software as a service to aid early diagnosis of degenerative disease...